Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation

Clinical trial NCT07488975 · RECRUITING

Trial details

NCT number: NCT07488975
Sponsor: Leeuwenhoek Laboratories Co. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatotic Liver Disease

Start date: 2025-01-22
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.